Scientists given research cloning go-ahead (UK)
By BBC News,
BBC News
| 08. 11. 2004
The Human Fertilisation and Embryology Authority granted the licence to experts at the University of Newcastle.
They are investigating new treatments for conditions including diabetes, Parkinson's and Alzheimer's disease.
The controversial decision could open a new era of research by scientists looking for remedies for diseases.
| |
This is an important area of research and a responsible use of technology
Suzi Leather, Human Fertilisation and Embryology Authority Listen to her interview
|
The research will take place at the International Centre for Life in Newcastle, involving experts from the Institute of Human Genetics at Newcastle University, and the Newcastle Fertility Centre.
Scientists there believe this is the first time such a licence has been granted in any European country.
They warn it will be at least five years - if not many more - before patients could receive stem cell treatments based on their work.
But the ProLife Party has said it is considering mounting a legal challenge against the HFEA's decision to allow the research to go ahead.
Support
...
Related Articles
By Jan Grue, The Guardian | 10.27.2026
For a very long time, I dreamed of being cured. I was born in 1981. I learned to walk early enough, but I stumbled and fell more easily than other children. My parents began to worry that something was wrong...
By staff, We Are Egg Donors | 10.21.2026
Michelle Lambrechts is a police officer and one-time egg donor in Belgium. She is also the founder of Ik Zit Met Een Ei, a Belgian nonprofit that advocates for egg donors. (The name is a Dutch play on words...
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...
